|
FY2025
12 months to Jan 31, 2026
|
FY2024
12 months to Feb 1, 2025
|
FY2023
12 months to Feb 3, 2024
|
FY2022
12 months to Jan 28, 2023
|
FY2021
12 months to Jan 29, 2022
|
|
|---|---|---|---|---|---|
| Operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Share-based compensation expense | |||||
| Deferred income tax (benefit) expense | |||||
| Other non-cash expenses | |||||
| Changes in operating assets and liabilities: | |||||
| Inventories | |||||
| Prepaid income taxes and tax receivable | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable | |||||
| Income taxes payable | |||||
| Accrued salaries and wages | |||||
| Operating leases | |||||
| Other accrued expenses | |||||
| Net cash provided by operating activities | |||||
| Investing activities: | |||||
| Purchases of investment securities and other investments | |||||
| Sales, maturities, and redemptions of investment securities | |||||
| Capital expenditures | |||||
| Net cash used in investing activities | |||||
| Financing activities: | |||||
| Cash paid for Revolving Credit Facility financing costs | |||||
| Net proceeds from issuance of common stock | |||||
| Repurchase and retirement of common stock | |||||
| Proceeds from exercise of options to purchase common stock and vesting of restricted and performance-based restricted stock units | |||||
| Common shares withheld for taxes | |||||
| Net cash used in financing activities | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at end of year | |||||
| Supplemental Cash Flow Information | |||||
| Supplemental disclosures of cash flow information: | |||||
| Interest paid | |||||
| Income taxes paid | |||||
| Non-cash investing activities | |||||
| (Decrease) increase in accounts payable and accrued purchases of property and equipment | |||||
Loading...